{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T12:34:06Z","timestamp":1703594046565},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To examine trends in the incidence, characteristics and outcomes, and to identify factors associated with in-hospital mortality (IHM) of patients hospitalized for primary pulmonary hypertension (PPH) in Spain (2004\u20132015).<\/jats:p>\n            <jats:p>We included all patients hospitalized with PPH and included in the Spanish National Hospital Discharge Database.<\/jats:p>\n            <jats:p>We analyzed 46,883 discharges of patients (7.14% with PPH as their primary diagnosis). Incidence rates decreased from 6.15 cases per 100,000 inhabitants in 2004\u201306 to 3.40 in 2013\u201315 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). Mean age rose from 66.43\u200a\u00b1\u200a21.28 to 69.73\u200a\u00b1\u200a21.12 years (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and the proportion of females increased over the study period (58.44% vs 60.71%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). Comorbidity using the Charlson Comorbidity Index (CCI) also increased with 16.07% having CCI \u22653 in 2004\u201306 vs 21.795 in 2013\u201315. Median length of hospital stay (LOHS) was 1 day longer in period 2004\u201306, than in 2013\u201315 (9 vs 8 days; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). The proportion of patients who were considered a readmission and the mean costs increased from 15.7% and 3712.46\u20ac in the first period to 17.14% and 4040.28\u20ac in 2013\u201315 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). IHM increased from 8.2% in 2004\u201306 to 9.93% in 2013\u201315 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). The predictors\u2019 of IHM among PPH patients included comorbidity and use of mechanical ventilation. Primary diagnosis of PPH did not predict higher IHM (OR 1.07; 95%CI 09\u20131.26).<\/jats:p>\n            <jats:p>Our data indicates that the incidence of hospitalizations decreased in Spain between 2004 and 2015. Parallel, LOHS also decreased during this period. By contrast, comorbidity increased over time in PPH patients, as well as readmission rates, costs and IHM.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000015518","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T11:02:08Z","timestamp":1556794928000},"page":"e15518","source":"Crossref","is-referenced-by-count":4,"title":["Retrospective observational analysis of hospital discharge database to characterize primary pulmonary hypertension and its outcomes in Spain from 2004 to 2015"],"prefix":"10.1097","volume":"98","author":[{"given":"Javier","family":"de-Miguel-D\u00edez","sequence":"first","affiliation":[{"name":"Respiratory Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Lopez-de-Andres","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Universidad Rey Juan Carlos, Alcorc\u00f3n"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Hernandez-Barrera","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Universidad Rey Juan Carlos, Alcorc\u00f3n"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Jimenez-Trujillo","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Universidad Rey Juan Carlos, Alcorc\u00f3n"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Mendez-Bailon","sequence":"additional","affiliation":[{"name":"Internal Medicine Department. Hospital Universitario Cl\u00ednico San Carlos, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"de Miguel-Yanes","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Facultad de Medicina, Universidad Complutense de Madrid (UCM)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Mu\u00f1oz-Rivas","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hospital Universitario Infanta Leonor, Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Romero-Maroto","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Universidad Rey Juan Carlos, Alcorc\u00f3n"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Jimenez-Garcia","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Universidad Rey Juan Carlos, Alcorc\u00f3n"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/690007","article-title":"Pulmonary arterial hypertension in the USA: an epidemiological study in a large insured pediatric population","volume":"7","author":"Li","year":"2017","journal-title":"Pulm Circ"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10741-015-9510-y","article-title":"Definition, epidemiology and registries of pulmonary hypertension","volume":"21","author":"Awdish","year":"2016","journal-title":"Heart Fail Rev"},{"issue":"(25 Suppl)","key":"R3-20230914","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1378\/chest.10-0837","article-title":"International Classification of Diseases coding changes lead to profound declines in reported idiopathic pulmonary arterial hypertension mortality and hospitalizations: implications for database studies","volume":"139","author":"Link","year":"2011","journal-title":"Chest"},{"key":"R5-20230914","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018798613","article-title":"High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project","volume":"8","author":"Bergemann","year":"2018","journal-title":"Pulm Circ"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"R7-20230914","article-title":"Age, risk and outcomes in idiopathic pulmonary arterial hypertension","volume":"51","author":"Hoeper","year":"2018","journal-title":"Eur Respir J"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015\u200aESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/HCO.0000000000000583","article-title":"Advances in medical therapy for pulmonary arterial hypertension","volume":"34","author":"Sisniega","year":"2019","journal-title":"Curr Opin Cardiol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijcard.2018.04.026","article-title":"National trends and outcomes of hospitalizations for pulmonary hypertension in Spain (2001-2014)","volume":"263","author":"De Miguel-D\u00edez","year":"2018","journal-title":"Int J Cardiol"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5603\/ARM.2017.0014","article-title":"Nationwide trends in inpatient admissions of pulmonary hypertension in the United States from 2000 to 2013","volume":"85","author":"Sikachi","year":"2017","journal-title":"Adv Respir Med"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1378\/chest.10-0075","article-title":"The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries","volume":"139","author":"Frost","year":"2011","journal-title":"Chest"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1378\/chest.06-1571","article-title":"Unexplained pulmonary hypertension in elderly patients","volume":"131","author":"Shapiro","year":"2007","journal-title":"Chest"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijcard.2012.10.026","article-title":"Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry","volume":"168","author":"Hoeper","year":"2013","journal-title":"Int J Cardiol"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1378\/chest.11-3241","article-title":"Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis","volume":"144","author":"Poms","year":"2013","journal-title":"Chest"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1378\/chest.13-1900","article-title":"Causes of pulmonary hypertension in the elderly","volume":"146","author":"Pugh","year":"2014","journal-title":"Chest"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/13993003.02310-2017","article-title":"Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension","volume":"51","author":"Hjalmarsson","year":"2018","journal-title":"Eur Respir J"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.phrs.2016.10.018","article-title":"Gender-related differences in pulmonary arterial hypertension targeted drugs administration","volume":"114","author":"Marra","year":"2016","journal-title":"Pharmacol Res"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.11-1387","article-title":"Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18\u200amm Hg: insights from the REVEAL Registry","volume":"143","author":"Frost","year":"2013","journal-title":"Chest"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jamacardio.2016.3591","article-title":"Trends and outcomes of pulmonary arterial hypertension-related hospitalizations in the United States: Analysis of the nationwide inpatient sample database from 2001 through 2012","volume":"1","author":"Anand","year":"2016","journal-title":"JAMA Cardiol"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamacardio.2016.3829","article-title":"Beast of pulmonary arterial hypertension burden","volume":"1","author":"Mathai","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"(3 Suppl)","key":"R28-20230914","first-page":"s47","article-title":"Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study","volume":"21","author":"Burke","year":"2015","journal-title":"Am J Manag Care"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/681226","article-title":"Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009","volume":"5","author":"Frank","year":"2015","journal-title":"Pulm Circ"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.recesp.2016.12.029","article-title":"Trends in pulmonary hypertension over a period of 30 years: Experience from a single referral centre","volume":"70","author":"Quezada Loaiza","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/ctr.12692","article-title":"Pulmonary hypertension as a risk factor of mortality after lung transplantation","volume":"30","author":"Andersen","year":"2016","journal-title":"Clin Transplant"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"105864","DOI":"10.1155\/2014\/105864","article-title":"Trends in pulmonary hypertension mortality and morbidity","volume":"2014","author":"Mehari","year":"2014","journal-title":"Pulm Med"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.14-0527","article-title":"Pulmonary hypertension surveillance: United States, 2001 to 2010","volume":"146","author":"George","year":"2014","journal-title":"Chest"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201905030-00089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:29:23Z","timestamp":1694726963000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201905030-00089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":31,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000015518","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}